Arcus Biosciences Stock (NYSE: RCUS) stock price, news, charts, stock research, profile.
Open | $13.87 |
Close | $14.12 |
Volume / Avg. | 871.56K / 700.86K |
Day Range | 13.61 - 14.35 |
52 Wk Range | 12.95 - 25.47 |
Market Cap | $1.25B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 33 |
Short Interest | 18.06% |
Days to Cover | 10.08 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Arcus Biosciences (NYSE:RCUS) through any online brokerage.
Other companies in Arcus Biosciences’s space includes: Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Immatics (NASDAQ:IMTX), Arcutis Biotherapeutics (NASDAQ:ARQT) and Prothena Corp (NASDAQ:PRTA).
There is no analysis for Arcus Biosciences.
Arcus Biosciences has a consensus price target of $41.47.
The stock price for Arcus Biosciences (NYSE: RCUS) is $13.73 last updated Today at July 5, 2024 at 9:28 AM EDT.
There are no upcoming dividends for Arcus Biosciences.
Arcus Biosciences’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Arcus Biosciences.
Arcus Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.